公司产品与技术 - Aptar Group公司的Bidose液体鼻喷雾系统被用于递送新获批的CARDAMYST鼻喷雾剂 [1] - CARDAMYST鼻喷雾剂获得美国食品药品监督管理局批准用于将阵发性室上性心动过速的急性症状发作转为窦性心律 [1] 行业与市场动态 - 全球药物和消费品给药、分配及保护技术领域的领先公司Aptar Group宣布其产品成为新获批药物的递送机制 [1]

FDA Approval Investor Call December 15, 2025 Forward Looking Statements The Presentation contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. Words such as ''aim,'' ''anticipate,'' ''assume,'' ''believe,'' ''contemplate,'' ''continue,'' ''could,'' ''design,'' ''due,'' ''estimate,'' ''expect,'' ''goal,'' ''intend,'' ''may,'' ''objective,'' ''plan,'' ''predict,'' ''positioned,'' ''potential,'' ''project,'' ''s ...